Punch & Associates Investment Management’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Punch & Associates Investment Management’s Portfolio ASTX Stock Details ASTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-14,330	Closed	-$122K	–	215
2013 Q3	$122K	Buy	+14,330	New	+$90.7K	0.02%	200

Punch & Associates Investment Management's ASTX Position: Q4 2013 in Review

Punch & Associates Investment Management sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 14,330 shares — an estimated $122K sold.

Punch & Associates Investment Management first reported a position in ASTX in Q3 2013 and held it in 1 quarter. The position peaked at $122K in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

Punch & Associates Investment Management reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
Punch & Associates Investment Management sold 14,330 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $122K.
Punch & Associates Investment Management first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q3 2013 and held it in 1 quarter.
Punch & Associates Investment Management's ASTEX PHARMACEUTICALS, INC COM position peaked at $122K in Q3 2013.
0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Punch & Associates Investment Management's 13F filing for Q4 2013, filed 7 Feb 2014.